NCT02799030 - A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Actinic Keratosis

Interventions

DRUG

BF-200 ALA 1%

topical treatment for photodynamic therapy combining drug application and after 3 h of drug incubation subsequent illumination with a broad spectrum light source .

DRUG

BF-200 ALA 3%

topical treatment for photodynamic therapy combining drug application and after 3 h of drug incubation subsequent illumination with a broad spectrum light source .

DRUG

BF-200 ALA 10%

topical treatment for photodynamic therapy combining drug application and after 3 h of drug incubation subsequent illumination with a broad spectrum light source .